These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36408725)
1. Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema. Huang Y; Linghu M; Hu W; Huang X J Clin Lab Anal; 2022 Dec; 36(12):e24774. PubMed ID: 36408725 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion. Song W; Jiao W; Li F; Ma A; Zhao B Biomed Res Int; 2020; 2020():9046781. PubMed ID: 32685542 [TBL] [Abstract][Full Text] [Related]
3. Quantitative Analysis of Retinal Microvascular Changes after Conbercept Therapy in Branch Retinal Vein Occlusion Using Optical Coherence Tomography Angiography. Deng Y; Cai X; Zhang S; Su L; Chen H; Lin Y; Sun L; Chen G; Zhong L; Jin C; Chi W Ophthalmologica; 2019; 242(2):69-80. PubMed ID: 31112969 [TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography angiography for macular microvessels in ischemic branch retinal vein occlusion treated with conbercept: predictive factors for the prognosis. Tang L; Sun GL; Zhao Y; Yang TT; Yao J Int J Ophthalmol; 2023; 16(12):2049-2055. PubMed ID: 38111937 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion. Li F; Sun M; Guo J; Ma A; Zhao B Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077 [TBL] [Abstract][Full Text] [Related]
6. Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions. Ding X; Wang Y; Zou B; Zang D; Hao Y Int J Gen Med; 2022; 15():7311-7318. PubMed ID: 36133911 [TBL] [Abstract][Full Text] [Related]
7. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect. Dărăbuș DM; Pac CP; Roşca C; Munteanu M Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516 [No Abstract] [Full Text] [Related]
8. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT. Tang F; Qin X; Lu J; Song P; Li M; Ma X Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282 [TBL] [Abstract][Full Text] [Related]
9. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept. Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591 [TBL] [Abstract][Full Text] [Related]
10. AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION. Yang KB; Sun XY; Sun LP; Li J; Liu ZL; Zhang H Retina; 2021 Apr; 41(4):834-843. PubMed ID: 33755650 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal Dexamethasone Implant Has Better Retinal Perfusion than Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion: A Five-Year Real-World Study. Zhang M; Liu Y; Song M; Yu Y; Ruan S; Zheng K; Wang F; Sun X Ophthalmic Res; 2023; 66(1):247-258. PubMed ID: 36215955 [TBL] [Abstract][Full Text] [Related]
12. Comparison of anti-VEGF results between non-ischemic branch retinal vein occlusion and ischemic branch retinal vein occlusion with early sector panretinal photocoagulation. Akdemir SC; Gunay BO J Fr Ophtalmol; 2022 Nov; 45(9):1042-1047. PubMed ID: 36127168 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity. Kim M; Jeong S; Sagong M Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671 [TBL] [Abstract][Full Text] [Related]
14. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes. Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. Lim JW Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections. Chen X; Hu TM; Zuo J; Wu H; Liu ZH; Zhan YX; Xia Y; Wang J; Wei W BMC Ophthalmol; 2020 Jun; 20(1):225. PubMed ID: 32527234 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study. Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema. Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685 [No Abstract] [Full Text] [Related]
19. Aqueous humor inflammatory cytokine levels and choroidal thickness in patients with macular edema associated with branch retinal vein occlusion. An Y; Park SP; Kim YK Int Ophthalmol; 2021 Jul; 41(7):2433-2444. PubMed ID: 33740201 [TBL] [Abstract][Full Text] [Related]
20. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study. Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]